Giuditta Mannelli

The molecular markers of cancer stem cells in head and neck tumors

Head and neck squamous cell carcinoma

Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities

Tumor-suppressor genes, cell cycle regulatory checkpoints, and the skin

Silver Nanoparticles Synthesized Using Carica papaya Leaf Extract (AgNPs-PLE) Causes Cell Cycle Arrest and Apoptosis in Human Prostate (DU145) Cancer Cells

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy

Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science

Relationship between CD44^high/CD133^high/CD117^high cancer stem cells phenotype and Cetuximab and Paclitaxel treatment response in head and neck cancer cell lines.

Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation

Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study

Risk Factors for Multiple Malignancies in the Head and Neck